Abstract: The invention relates to an in vitro method for detecting or monitoring an endometrial or ovarian carcinoma in a human subject, which method comprises detecting, or determining the level of, methylation of OXT and/or ZSCAN12 gene in a biological sample from the subject.

Abstract: The invention relates to methods for quantifying a SARS coronavirus in a blood sample of a subject, and for determining a risk for the subject to develop a severe form of the disease or for the disease to worsen.

Abstract: The present invention relates to the field of oncology, particularly the early diagnostic of lung cancer, the monitoring of lung cancer patients and the prediction of the clinical outcome of patients. The invention relates to a method for diagnosing lung cancer or diagnosing relapse of lung cancer in patients by determination of the level of methylation of gene(s) and the kit to implement said method.

Abstract: The invention relates to methods for determining the severity of a disease caused by a coronavirus infection, comprising quantifying the level of cellular RNA of RNase P in a blood sample of a subject.

Abstract: The invention relates to a method for diagnosing or identifying gastric cancer in a subject. The inventors indeed identified three DNA methylation biomarkers that, alone, or preferably in combination, can help diagnosing or following-up gastric cancer patients very specifically, discriminating with other type of cancers. Further, it can be used for determining, and/or adapting a suitable therapeutic regimen for a subject diagnosed for gastric cancer. The present invention also relates to kits comprising primers or probes to detect, diagnose, or identify hypermethylated genes.

Abstract: The present invention relates to a digital multiplex method for detecting and/or quantifying multiple target biomolecules in a sample, said biomolecules being selected from DNA, RNA, and proteins. The present invention further relates to different applications of the digital multiplex method and to a kit.

Abstract: The present invention relates to a digital method for detecting and/or quantifying at least one target biomolecules in a sample, said biomolecules being selected from DNA, RNA, and proteins based on isothermal amplification. The present invention further relates to different applications of the digital method and to a kit.

Abstract: The invention relates to a method for diagnosing or identifying pancreas cancer in a subject. The inventors indeed identified two DNA methylation biomarkers that, alone, preferably in combination, can help diagnosing or following-up pancreatic cancer patients very specifically, discriminating with other type of cancers. Further, it can be used for determining, adapting a suitable therapeutic regimen for a subject diagnosed for pancreas cancer. The present invention also relates to kit comprising primers or probes to detect, diagnose, identify hypermethylated genes.